SABAX Performance — Saratoga Aggressive Balanced Allocation Portfolio, Class A
Data updated: 2026-07-24
SABAX returned +6.08% year to date and +16.91% over one year to May 2026. Annualised returns are +14.55% over 3 years and +7.37% over 5 years. Against its US Multi-Cap Blend category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $150, against $147 for the category, and to $117 over one year, against $119. Volatility over the past three years was 10.30% a year. In the 12 months to May 2026 the fund took in a net $203K, and assets reached $1.86M.
SABAX Growth of $100
What $100 invested in Saratoga Aggressive Balanced Allocation Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Blend category average over the same months.
| Period | SABAX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $117 | $119 |
| 3 years (Jun 2023 – May 2026) | $150 | $147 |
| 5 years (Jun 2021 – May 2026) | $143 | $136 |
| Since data start (Mar 2020 – May 2026) | $185 | $173 |
SABAX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.08% |
| 1 year | +16.91% |
| 3 years (annualised) | +14.55% |
| 5 years (annualised) | +7.37% |
SABAX Annual Returns
Calendar-year total returns of Saratoga Aggressive Balanced Allocation Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +6.08% |
| 2025 | +12.65% |
| 2024 | +12.21% |
| 2023 | +14.92% |
| 2022 | −11.39% |
| 2021 | +14.68% |
| 2020 (Mar–Dec) | +18.17% |
SABAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.5% | +0.7% | −5.2% | +6.7% | +2.6% | — | — | — | — | — | — | — |
| 2025 | +3.3% | −2.3% | −3.7% | +0.5% | +4.6% | +3.6% | +1.3% | +1.8% | +1.6% | +0.8% | +1.0% | −0.1% |
| 2024 | +0.4% | +4.2% | +2.5% | −3.8% | +2.8% | +0.4% | +2.4% | +0.9% | +1.5% | −0.5% | +4.7% | −3.5% |
| 2023 | +5.6% | −1.7% | −0.7% | 0.0% | −0.6% | +4.9% | +2.2% | −1.5% | −2.9% | −2.4% | +6.6% | +5.0% |
| 2022 | −4.1% | −0.4% | +1.1% | −5.5% | +0.4% | −6.1% | +5.9% | −1.9% | −6.7% | +5.2% | +4.8% | −3.6% |
| 2021 | +0.4% | +2.6% | +2.6% | +3.2% | +0.7% | +0.9% | 0.0% | +1.8% | −2.9% | +3.9% | −2.3% | +3.2% |
| 2020 | — | — | −12.0% | +9.4% | +3.6% | +1.2% | +3.6% | +4.1% | −2.7% | −1.6% | +9.4% | +3.6% |
SABAX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 10.30%
- 3-year Sharpe ratio: 0.98 (vs 4.5% risk-free rate)
- Best month: +6.69% (Apr 2026)
- Worst month: −5.20% (Mar 2026)
SABAX Fund Flows
Monthly money in and out of Saratoga Aggressive Balanced Allocation Portfolio, from SEC Form N-PORT.
- 12-month net flow: $203K
- 12-month gross sales (incl. reinvestments): $235K
- Sales ÷ redemptions: 7.38×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $2K | $0 | $2K |
| Apr 2026 | $3K | $0 | $3K |
| Mar 2026 | $7K | $0 | $7K |
| Feb 2026 | $1K | $3K | −$2K |
| Jan 2026 | $56K | $4K | $52K |
| Dec 2025 | $153K | $15 | $153K |
| Nov 2025 | $1K | $0 | $1K |
| Oct 2025 | $2K | $17K | −$15K |
| Sep 2025 | $2K | $4K | −$2K |
| Aug 2025 | $2K | $0 | $2K |
| Jul 2025 | $3K | $0 | $3K |
| Jun 2025 | $1K | $4K | −$3K |
SABAX Assets Under Management
Net assets of Saratoga Aggressive Balanced Allocation Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $1.86M |
| 2026-02-28 | $1.78M |
| 2025-11-30 | $1.69M |
| 2025-08-31 | $1.65M |
| 2025-05-31 | $1.54M |
| 2025-02-28 | $1.47M |
| 2024-11-30 | $1.49M |
| 2024-08-31 | $1.41M |
| 2024-05-31 | $1.29M |
| 2024-02-29 | $1.27M |
| 2023-11-30 | $1.15M |
| 2023-08-31 | $1.14M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.